Organogenesis Holdings Inc. Reports Second Quarter and First Half 2021 Financial Results
CANTON, Mass., Aug. 09, 2021 (GLOBE NEWSWIRE) — Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading…
Month: August 2021
Turning Point Therapeutics Reports Second-Quarter Financial Results, Provides Operational Updates
Phase 1/2 TRIDENT-1 Enrollment Reaches Approximately 300 Patients, Including More than 50 in the ROS1-Positive…
BioCryst Commences Public Offering of Common Stock and Pre-Funded Warrants
RESEARCH TRIANGLE PARK, N.C., Aug. 09, 2021 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX)…
Cara Therapeutics Reports Second Quarter 2021 Financial Results
– New Drug Application (NDA) Filing for KORSUVA™ Injection in CKD-aP under Priority Review by…
Apellis Pharmaceuticals Reports Second Quarter 2021 Financial Results
Received approval for EMPAVELI™ (pegcetacoplan) – the first targeted C3 therapy – from U.S. Food and…
Impel NeuroPharma to Report Second Quarter 2021 Financial Results on Monday, August 16, 2021
SEATTLE, Aug. 09, 2021 (GLOBE NEWSWIRE) — Impel NeuroPharma, Inc. (NASDAQ: IMPL), a late-stage biopharmaceutical…
FibroGen Reports Second Quarter 2021 Financial Results
• Roxadustat net product revenue in China of $13.4 million, on a US GAAP basis. •…
NexImmune to Explore the Use of AIM™ Direct Injection Technology in Type 1 Diabetes
GAITHERSBURG, Md., Aug. 09, 2021 (GLOBE NEWSWIRE) — NexImmune, Inc. (Nasdaq: NEXI), a clinical-stage biotechnology company…
Organogenesis Holdings Inc. Announces New $200 Million Credit Agreement with Silicon Valley Bank
CANTON, Mass., Aug. 09, 2021 (GLOBE NEWSWIRE) — Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading…
Adaptimmune Reports Second Quarter Financial Results and Business Update
– SPEARHEAD-1 data presented at ASCO with overall response rate of 39.3% in synovial sarcoma…
Sorrento Unveils Overview of Its MultiValent mRNA COVID-19 Vaccine Development Program
SAN DIEGO, Aug. 09, 2021 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”), a…
Consortium for Top-Down Proteomics Launches New Initiative for the CE-MS of Intact Proteins and Protein Complexes
Enhanced methods will provide proteoform-specific knowledge critical for understanding biological function and developing new biopharmaceutical…
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons on 5 August 2021
Bagsværd, Denmark, 9 August 2021 — This company announcement discloses the data of the transaction(s)…
GoodRx and Boehringer Ingelheim Announce Joint Effort to Deliver Affordability Solutions to Patients
Potential to provide approximately $15 million a year in savings for life-enhancing medications SANTA MONICA,…
Acer Therapeutics and Relief Therapeutics Announce Submission of a New Drug Application to the U.S. FDA for ACER-001 for Treatment of Urea Cycle Disorders
NEWTON, Mass. and GENEVA, Aug. 09, 2021 (GLOBE NEWSWIRE) — Acer Therapeutics Inc. (Nasdaq: ACER)…
Longboard Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2021 Financial Results
Continued progress with the multiple ascending dose (MAD) portion of the Phase 1 clinical trial…
United Soybean Board Awards $1 Million to Amfora to Continue Development of High-Protein Soy
Award reflects effort to maintain U.S. soy farmers’ global market share SAN FRANCISCO, Aug. 09,…
TRACON Pharmaceuticals Announces Results of Second Independent Data Monitoring Committee Review of Safety Data from ENVASARC Pivotal Trial
– Trial to Continue as Planned SAN DIEGO, Aug. 09, 2021 (GLOBE NEWSWIRE) — TRACON…
Nautilus Biotechnology Appoints Karl Voss, Ph.D., as Vice President of Life Sciences Research and Development
Former Pacific Biosciences executive brings deep expertise in single-molecule analysis to large-scale platform designed to…
Avadel Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2021 Financial Results
Commercial and launch preparations on track to support potential U.S. FDA approval of FT218 for…